JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00308-07v1
81/14/7476    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finzi, A.
Right arrow Articles by Cohen, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finzi, A.
Right arrow Articles by Cohen, E. A.

 Previous Article  |  Next Article 

Journal of Virology, July 2007, p. 7476-7490, Vol. 81, No. 14
0022-538X/07/$08.00+0     doi:10.1128/JVI.00308-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Productive Human Immunodeficiency Virus Type 1 Assembly Takes Place at the Plasma Membrane{triangledown}

Andrés Finzi,1 Alexandre Orthwein,1 Johanne Mercier,1 and Éric A. Cohen1,2*

Laboratory of Human Retrovirology, Institut de Recherches Cliniques de Montréal,1 Department of Microbiology and Immunology, Université de Montréal, Montreal, Quebec, Canada2

Received 12 February 2007/ Accepted 3 May 2007

Gag proteins are necessary and sufficient to direct human immunodeficiency virus type 1 (HIV-1) particle assembly and budding. Recent evidence suggests that Gag targeting to late endosomal/multivesicular body (LE/MVB) compartments occurs prior to viral particle budding at the plasma membrane (PM). However, the route that Gag follows before reaching its steady-state destinations still remains a subject of debate. Using a subcellular fractionation method that separates PM from LE/MVB combined with pulse-chase labeling, we analyzed Gag trafficking in HIV-1-producing HEK 293T cells. Our results reveal that the majority of newly synthesized Gag is primarily targeted to the PM. While PM-targeted Gag was efficiently released, a significant fraction of the remaining cell surface-associated Gag was found to be subsequently internalized to LE/MVB, where it accumulated, thus accounting for the majority of LE/MVB-associated Gag. Importantly, this accumulation of Gag in LE/MVB was found to be cholesterol dependent since it was sensitive to the sterol-binding drugs filipin and methyl-ß-cyclodextrin. These results point towards the PM as being the primary site of productive HIV-1 assembly in cells that also support Gag accumulation in intracellular compartments.


* Corresponding author. Mailing address: Laboratory of Human Retrovirology, Institut de Recherches Cliniques de Montréal (IRCM), 110, Avenue des Pins Ouest, Montreal, Quebec, Canada H2W 1R7. Phone: (514) 987-5804. Fax: (514) 987-5691. E-mail: eric.cohen{at}ircm.qc.ca

{triangledown} Published ahead of print on 16 May 2007.


Journal of Virology, July 2007, p. 7476-7490, Vol. 81, No. 14
0022-538X/07/$08.00+0     doi:10.1128/JVI.00308-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.